QQQ   427.52 (+0.39%)
AAPL   168.11 (+0.07%)
MSFT   410.42 (-0.34%)
META   509.50 (+3.10%)
GOOGL   156.13 (+0.42%)
AMZN   182.07 (+0.44%)
TSLA   151.04 (-2.84%)
NVDA   851.48 (+1.32%)
AMD   156.13 (+1.37%)
NIO   4.05 (+3.58%)
BABA   69.42 (+0.87%)
T   16.20 (+0.50%)
F   12.14 (+0.83%)
MU   115.33 (-0.86%)
GE   156.85 (+0.76%)
CGC   7.56 (+16.49%)
DIS   113.92 (+0.87%)
AMC   2.90 (-2.68%)
PFE   25.41 (-0.04%)
PYPL   63.00 (-0.41%)
XOM   118.98 (+0.30%)
QQQ   427.52 (+0.39%)
AAPL   168.11 (+0.07%)
MSFT   410.42 (-0.34%)
META   509.50 (+3.10%)
GOOGL   156.13 (+0.42%)
AMZN   182.07 (+0.44%)
TSLA   151.04 (-2.84%)
NVDA   851.48 (+1.32%)
AMD   156.13 (+1.37%)
NIO   4.05 (+3.58%)
BABA   69.42 (+0.87%)
T   16.20 (+0.50%)
F   12.14 (+0.83%)
MU   115.33 (-0.86%)
GE   156.85 (+0.76%)
CGC   7.56 (+16.49%)
DIS   113.92 (+0.87%)
AMC   2.90 (-2.68%)
PFE   25.41 (-0.04%)
PYPL   63.00 (-0.41%)
XOM   118.98 (+0.30%)
QQQ   427.52 (+0.39%)
AAPL   168.11 (+0.07%)
MSFT   410.42 (-0.34%)
META   509.50 (+3.10%)
GOOGL   156.13 (+0.42%)
AMZN   182.07 (+0.44%)
TSLA   151.04 (-2.84%)
NVDA   851.48 (+1.32%)
AMD   156.13 (+1.37%)
NIO   4.05 (+3.58%)
BABA   69.42 (+0.87%)
T   16.20 (+0.50%)
F   12.14 (+0.83%)
MU   115.33 (-0.86%)
GE   156.85 (+0.76%)
CGC   7.56 (+16.49%)
DIS   113.92 (+0.87%)
AMC   2.90 (-2.68%)
PFE   25.41 (-0.04%)
PYPL   63.00 (-0.41%)
XOM   118.98 (+0.30%)
QQQ   427.52 (+0.39%)
AAPL   168.11 (+0.07%)
MSFT   410.42 (-0.34%)
META   509.50 (+3.10%)
GOOGL   156.13 (+0.42%)
AMZN   182.07 (+0.44%)
TSLA   151.04 (-2.84%)
NVDA   851.48 (+1.32%)
AMD   156.13 (+1.37%)
NIO   4.05 (+3.58%)
BABA   69.42 (+0.87%)
T   16.20 (+0.50%)
F   12.14 (+0.83%)
MU   115.33 (-0.86%)
GE   156.85 (+0.76%)
CGC   7.56 (+16.49%)
DIS   113.92 (+0.87%)
AMC   2.90 (-2.68%)
PFE   25.41 (-0.04%)
PYPL   63.00 (-0.41%)
XOM   118.98 (+0.30%)

Global X S&P Biotech ETF (CURE) News Today

SourceHeadline
finanznachrichten.de logoModerna, Inc.: Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
finanznachrichten.de - March 28 at 11:59 PM
seekingalpha.com logoXBI: Biotech Is A Strong Buy As M&A Activity Picks Up (Rating Upgrade)
seekingalpha.com - March 20 at 5:50 AM
msn.com logoBiotech group backs anti-China bill; part ways with WuXi AppTec
msn.com - March 14 at 8:41 AM
finance.yahoo.com logoX-Therma's $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation
finance.yahoo.com - March 13 at 8:20 PM
markets.businessinsider.com logoKrystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
markets.businessinsider.com - February 26 at 9:57 AM
finance.yahoo.com logoSaudi Aramco and FT accused of running misleading ‘sustainable’ fuel adverts
finance.yahoo.com - February 22 at 3:00 PM
marketwatch.com logoLIXTE Biotechnology Shares Rise 14% After First Patient Dosed in LB-100 Trial
marketwatch.com - January 29 at 10:21 AM
finance.yahoo.com logoHuman Microbiome Therapeutics Market Size and Share Expected to Cross USD 3,917.01 Million By 2032, at 22.7% CAGR: Polaris Market Research
finance.yahoo.com - January 11 at 12:37 PM
finance.yahoo.com logoU.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
finance.yahoo.com - January 11 at 7:36 AM
finance.yahoo.com logoGlobal $16.2B Research Antibodies & Reagents Market by Product, Technology, Application, End User & Region - Forecast to 2028
finance.yahoo.com - January 10 at 2:55 PM
finance.yahoo.com logoBone Wax Market to Reach USD 107.8 billion by 2031, Rising at a CAGR of 3.3% | Transparency Market Research, Inc.
finance.yahoo.com - January 10 at 3:28 AM
finance.yahoo.com logoDefence's AccuTOX(R) Impairs Lung Cancer Growth
finance.yahoo.com - January 10 at 3:28 AM
markets.businessinsider.com logoGlobal Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
markets.businessinsider.com - January 9 at 11:55 AM
msn.com logoEli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
msn.com - January 5 at 9:09 AM
msn.com logoBiotechtech Stocks Find a Cure: M&A
msn.com - December 29 at 11:50 PM
markets.businessinsider.com logoThese 3 Biotech Stocks Have Strong Upside Potential, Says Deutsche Bank
markets.businessinsider.com - December 17 at 6:21 PM
msn.com logoCheck out the renovations at the Kohler Waters Spa
msn.com - December 13 at 7:58 AM
markets.businessinsider.com logoHere's what to expect from Burning Rock Biotech's earnings report
markets.businessinsider.com - November 29 at 9:32 AM
msn.com logoNew ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade
msn.com - November 22 at 8:32 AM
markets.businessinsider.com logo7 Underappreciated Biotech Stocks to Pick Up on the Cheap
markets.businessinsider.com - November 9 at 10:39 PM
markets.businessinsider.com logoRobust Financial Performance and Promising Gene Therapy Pipeline Bolster Krystal Biotech’s Buy Rating
markets.businessinsider.com - November 7 at 8:33 AM
markets.businessinsider.com logoCidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
markets.businessinsider.com - November 2 at 5:39 PM
fool.com logoIntellia Therapeutics Will Soon Make Biotech History. Is the Stock a Buy?
fool.com - October 28 at 7:35 AM
benzinga.com logoGlobal X ETFs Ranked Among Best Places to Work in New York by Crain's New York Business
benzinga.com - September 28 at 3:45 PM
insidermonkey.com logo5 Best Pharma ETFs
insidermonkey.com - September 12 at 6:04 PM
markets.businessinsider.com logoKrystal Biotech (KRYS) Receives a New Rating from Berenberg Bank
markets.businessinsider.com - September 6 at 5:53 PM
benzinga.com logoDiverse Biotech Announces New Patent Approval for Its PEMBROLIZUMAB Antibody Drug DBT-50201
benzinga.com - August 30 at 8:02 AM
marketwatch.com logoAxcella Therapeutics Gets Patent for Long Covid Treatment
marketwatch.com - August 30 at 8:02 AM
msn.com logoBetter Therapeutics stock surges on ‘big milestone’ after FDA approves smartphone-based diabetes treatment
msn.com - July 11 at 12:16 AM
benzinga.com logoThese ETFs Let You Maximize Your Exposure To The Biotech Industry's Performance – Whether Positive Or Inverse
benzinga.com - March 24 at 9:27 AM
thestreet.com logoETFs to Play Biotech M&A
thestreet.com - March 19 at 5:27 PM
benzinga.com logoGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM), Earnings Estimates, EPS, and Revenue
benzinga.com - March 7 at 7:20 AM
nasdaq.com logoGlobal X Launches 2 ESG-Focused Covered Call ETFs
nasdaq.com - February 24 at 2:57 PM
barrons.com logo7 Cheap But Risky Biotech Stocks
barrons.com - January 18 at 3:44 PM
benzinga.com logoUpdate on Acticor Biotech's clinical developments with glenzocimab in the treatment of cardiovascular emergencies
benzinga.com - January 11 at 6:26 PM
benzinga.com logoGlobal Spinal Muscular Atrophy Treatment Market Report 2022: Sector to Reach $11.4 Billion by 2028 at a 17.8% CAGR
benzinga.com - January 9 at 1:38 PM
cnbc.com logoBank of America just added these biotech stocks to its list of first-quarter picks
cnbc.com - January 8 at 11:46 PM
fool.com logoGlobal X Funds - Global X Genomics & Biotechnology ETF (NASDAQ: GNOM)
fool.com - January 7 at 1:43 PM
nasdaq.com logo3 Advancements in Biotech Investors Should Look Out for in 2023
nasdaq.com - January 5 at 3:10 PM
finance.yahoo.com logoGlobal X S&P Biotech ETF (CURE.AX)
finance.yahoo.com - October 17 at 8:46 PM
finance.yahoo.com logoBIOTECH IS ONE OF THE FIRST TO USE REGULATION CROWDFUNDING TO HELP FIND A CURE FOR CHEMICAL ADDICTION.
finance.yahoo.com - September 16 at 4:12 AM
finance.yahoo.com logoInnovation1 Biotech Appoints Frederick E. Pierce, II to its Board of Directors
finance.yahoo.com - September 15 at 1:05 PM
finance.yahoo.com logoQurAlis to Present at 22nd Annual Biotech in Europe Forum
finance.yahoo.com - September 14 at 10:03 PM
morningstar.com logoBiden signs executive order targeting biotech as he talks up 'cancer moonshot'
morningstar.com - September 14 at 10:15 AM
finance.yahoo.com logoFierce Biotech names Strand Therapeutics as one of its "Fierce 15" Biotech Companies of 2022
finance.yahoo.com - September 12 at 10:15 AM
benzinga.com logoThe 33rd Annual 65 Roses Ladies Golf Classic is Fundraising for a Cure!
benzinga.com - September 12 at 12:15 AM
msn.com logoCould This Biosimilar Drug Candidate Be a Winner for Amgen?
msn.com - September 9 at 4:32 PM
finance.yahoo.com logoCompugen to Participate in Upcoming Fierce Biotech Summit
finance.yahoo.com - September 7 at 8:23 AM
msn.com logoThe Best Biotech Stock to Own in September
msn.com - September 6 at 11:23 AM
benzinga.com logoMaine Auto Dealership Supports the Champion the Cure Challenge to Defeat Cancer
benzinga.com - September 3 at 6:49 PM
Get Global X S&P Biotech ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for CURE and its competitors with MarketBeat's FREE daily newsletter.

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

CURE Media Mentions By Week

CURE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CURE
News Sentiment

0.00

0.48

Average

News Sentiment

CURE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CURE Articles
This Week

0

0

CURE Articles
Average Week

Get Global X S&P Biotech ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for CURE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (ASX:CURE) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners